Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 476,304	$ 261,447
Available for sale securities	170,531	120,302
Prepaid expenses and other current assets	15,991	5,739
Total current assets	662,826	387,488
Property and equipment, net	946	348
Right-of-use assets, net	1,182	1,522
Other assets	1,869	0
Total assets	666,823	389,358
Current liabilities
Accrued research and development expenses	11,555	14,403
Accounts payable and accrued expenses	22,843	12,856
Lease liability, current	1,189	952
Total current liabilities	35,587	28,211
Lease liability, non-current	11	619
Debt, non-current	96,568	0
Total liabilities	132,166	28,830
Stockholders' equity
Preferred stock—$0.001 par value, 5,000,000 shares authorized, no shares issued or outstanding	0	0
Common stock—0.001 par value, 200,000,000 shares authorized, 136,639,687 and 115,277,012 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively	137	115
Additional paid-in capital	1,399,555	1,040,098
Accumulated deficit	(864,806)	(679,595)
Accumulated other comprehensive income	(229)	(90)
Total stockholders' equity	534,657	360,528
Total liabilities and stockholders' equity	$ 666,823	$ 389,358